Kärt Tomberg, ExpressionEdits
Artikel konnten nicht hinzugefügt werden
Der Titel konnte nicht zum Warenkorb hinzugefügt werden.
Der Titel konnte nicht zum Merkzettel hinzugefügt werden.
„Von Wunschzettel entfernen“ fehlgeschlagen.
„Podcast folgen“ fehlgeschlagen
„Podcast nicht mehr folgen“ fehlgeschlagen
-
Gesprochen von:
-
Von:
Über diesen Titel
What do you do when entrepreneurship calls and your partner lives overseas?
How much can you really delegate as a CEO?
Why does a 50-year-old gene expression problem still exist – and what happens if we solve it?
I’m joined by Kart Tomberg, CEO of ExpressionEdits based in Cambridge, UK. ExpressionEdits is a seed-stage company taking on the challenging bottlenecks going from DNA to protein and convincing cells to make proteins for us.
About LifeScience ORG
It’s no secret that Europe is a global leader in generating translational science. We’re grateful at LifeScience ORG to have a community of over 400 life science CEOs – leaders driving change in biotech, medtech, techBio and healthcare.
The conversations inside our community – stories of conviction, navigating challenges, and making bold decisions – inspire us every week. To hear the stories, lessons, and experiences of our life science leaders, listen to A Call to Lead @ LifeScience ORG, available on all good podcasting platforms.
Timestamps:
0:00 - Introduction & Background
2:52 - From Academia to Entrepreneurship
7:18 - Early Leadership Lessons
10:30 - The Two-Body Problem
13:39 - Challenges Facing Life Science CEOs
19:25 - Cambridge Ecosystem & European Life Science
22:59 - The Science: Protein Expression Challenge
30:45 - Leadership Philosophy & Delegation